Post-translational modifications of EZH2 in cancer

Enhancer of zeste homolog 2 (EZH2), as a main component of Polycomb Repressive Complex 2, catalyzes histone H3K27me3 to silence its target gene expression. EZH2 upregulation results in cancer development and poor prognosis of cancer patients. Post-translational modifications (PTMs) are important bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhongwei, Li, Minle, Wang, Diandian, Hou, Pingfu, Chen, Xintian, Chu, Sufang, Chai, Dafei, Zheng, Junnian, Bai, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731458/
https://www.ncbi.nlm.nih.gov/pubmed/33308321
http://dx.doi.org/10.1186/s13578-020-00505-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731458/
https://www.ncbi.nlm.nih.gov/pubmed/33308321
http://dx.doi.org/10.1186/s13578-020-00505-0

Ejemplares similares